ASPIRING to determine the safety and effectiveness of antiplatelet monotherapy after intracerebral haemorrhage: the Antiplatelet Secondary Prevention International Randomised trial after Intracerebral haemorrhaGe (ASPIRING)

被引：0
|
作者：
Hankey, Graeme [1 ]
Anderson, Craig [2 ]
Salman, Rustam Al-Shahi [3 ]
机构：
[1] Univ Western Australia, Perth, WA, Australia
[2] George Inst Global Hlth, Newtown, Tas, Australia
[3] Neurol Clin, Edinburgh, Midlothian, Scotland
来源：
INTERNATIONAL JOURNAL OF STROKE | 2022年 / 17卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
21
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [31] Anticoagulation with dabigatran does not increase secondary intracerebral haemorrhage after thrombolysis in experimental cerebral ischaemia
    Sun, Li
    Zhou, Wei
    Ploen, Robert
    Zorn, Markus
    Veltkamp, Roland
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (01) : 153 - 161
  • [32] Effects of blood pressure and tranexamic acid in spontaneous intracerebral haemorrhage: a secondary analysis of a large randomised controlled trial
    Appleton, Jason Philip
    Law, Zhe Kang
    Woodhouse, Lisa Jane
    Salman, Rustam Al-Shahi
    Beridze, Maia
    Christensen, Hanne
    Dineen, Robert A.
    Guerrero, Juan Jose Egea
    England, Timothy J.
    Karlinski, Michal
    Krishnan, Kailash
    Laska, Ann Charlotte
    Lyrer, Philippe
    Ozturk, Serefnur
    Roffe, Christine
    Roberts, Ian
    Robinson, Thompson G.
    Scutt, Polly
    Werring, David J.
    Bath, Philip M.
    Sprigg, Nikola
    BMJ NEUROLOGY OPEN, 2023, 5 (01)
  • [33] Blood pressure (BP) treatment after an intracerebral haemorrhage (ICH): Data from the on-going Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2) trial
    Sprigg, N.
    Robson, K. S.
    Krishnan, K.
    Bath, P. M.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 296 - 296
  • [34] Clinical and radiological predictors of cognitive impairment after intracerebral haemorrhage at day 365: data from the Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2) trial
    Belcher, A.
    Woodhouse, L.
    Bath, P. M.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (4_SUPPL) : 15 - 15
  • [35] Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial
    Desborough, Michael J. R.
    Salman, Rustam Al-Shahi
    Stanworth, Simon J.
    Havard, Diane
    Woodhouse, Lisa J.
    Craig, Jennifer
    Krishnan, Kailash
    Brennan, Paul M.
    Dineen, Robert A.
    Coats, Tim J.
    Hepburn, Trish
    Bath, Philip M.
    Sprigg, Nikola
    LANCET NEUROLOGY, 2023, 22 (07): : 557 - 567
  • [36] Characteristics and Outcomes of Patients on Prior Antiplatelet Therapy in the Tranexamic Acid in Primary Intracerebral Haemorrhage-2 (TICH-2) Trial
    Law, Zhe Kang
    Flaherty, Katie
    Appleton, Jason P.
    Scutt, Polly
    Krishnan, Kailash
    Ali, Azlinawati
    Dineen, Rob
    Bath, Philip M.
    Sprigg, Nikola
    STROKE, 2018, 49
  • [37] Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial
    Salman, Rustam Al-Shahi
    Minks, David P.
    Mitra, Dipayan
    Rodrigues, Mark A.
    Bhatnagar, Priya
    du Plessis, Johann C.
    Joshi, Yogish
    Dennis, Martin S.
    Murray, Gordon D.
    Newby, David E.
    Sandercock, Peter A. G.
    Sprigg, Nikola
    Stephen, Jacqueline
    Sudlow, Cathie L. M.
    Werring, David J.
    Whiteley, William N.
    Wardlaw, Joanna M.
    White, Philip M.
    Baigent, Colin
    Lasserson, Daniel S.
    Carrie, Johanna
    LANCET NEUROLOGY, 2019, 18 (07): : 643 - 652
  • [38] The Impact of Obesity on Antiplatelet Monotherapy for Secondary Prevention After Percutaneous Coronary Intervention: A Substudy of the HOST- EXAM Trial
    Han, Minju
    Kang, Jeehoon
    Kim, Bitna
    Hwang, Doyeon
    Yang, Han-Mo
    Park, Kyung Woo
    Han, Jung-Kyu
    Koo, Bon-Kwon
    Shin, Eun-Seok
    Kim, Hyo-Soo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (17) : B152 - B152
  • [39] Comparative Effectiveness and Safety of Antiplatelet Drug Regimens as Secondary Prevention After Ischemic Stroke or Transient Ischemic Attack
    Yasmina, Alfi
    de Boer, Anthonius
    Deneer, Vera H. M.
    ten Berg, Jurrien M.
    Groenwold, Rolf H. H.
    Souverein, Patrick C.
    Klungel, Olaf H.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 490 - 491
  • [40] APACHE-AF: Apixaban versus antiplatelet drugs or no antithrombotic treatment after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation. A randomized phase II clinical trial
    van Nieuwenhuizen, K. M.
    van der Worp, H. B.
    Algra, A.
    van Gelder, I. C.
    Kappelle, L. J.
    Rinkel, G. J. E.
    Schutgens, R. E. G.
    Klijn, C. J. M.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 433 - 433
12345